Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig model
<p>Abstract</p> <p>Background</p> <p>Congenital cytomegalovirus (CMV) infection is a major public health problem. Antiviral therapies administered during pregnancy might prevent vertical CMV transmission and disease in newborns, but these agents have not been evaluated...
Main Authors: | McGregor Alistair, Anderson Jodi L, Schleiss Mark R |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-03-01
|
Series: | Virology Journal |
Online Access: | http://www.virologyj.com/content/3/1/9 |
Similar Items
-
Genetically engineered live-attenuated cytomegalovirus (CMV) vaccines improve pregnancy outcome in the guinea-pig model of congenital CMV infection
by: Cui Xiaohong, et al.
Published: (2008-04-01) -
Analysis of the nucleotide sequence of the guinea pig cytomegalovirus (GPCMV) genome
by: Cui Xiaohong, et al.
Published: (2008-11-01) -
A Homolog Pentameric Complex Dictates Viral Epithelial Tropism, Pathogenicity and Congenital Infection Rate in Guinea Pig Cytomegalovirus.
by: Stewart Coleman, et al.
Published: (2016-07-01) -
Convalescent Immunity to Guinea Pig Cytomegalovirus Induces Limited Cross Strain Protection against Re-Infection but High-Level Protection against Congenital Disease
by: K. Yeon Choi, et al.
Published: (2020-08-01) -
Viral Glycoprotein Complex Formation, Essential Function and Immunogenicity in the Guinea Pig Model for Cytomegalovirus.
by: Stewart Coleman, et al.
Published: (2015-01-01)